Belite Bio, Inc ( BLTE) - Stock Earnings
BLTE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
BLTE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -25.3 million USD | — USD |
| 2026Q1 | -26.9 million USD | — USD |
| 2026Q2 | -28.4 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BLTE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.6 million USD | — USD |
| 2024 | -36.1 million USD | — USD |
| 2025 | -77.6 million USD | — USD |
| 2026 Est. | — | — |
BLTE
Price: $158.65
52 week price:
Earnings Per Share: -2.73 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 6.4 billion